Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 193.6M | 215.7M | 196.6M | 198.6M |
| Cost of revenue | 72.0M | 66.8M | 61.6M | 63.9M |
| Gross profit | 121.6M | 148.8M | 135.1M | 134.7M |
| Operating expense | ||||
| Research & development | 19.8M | 18.8M | 17.3M | 18.0M |
| Selling general and admin | 133.0M | 136.5M | 130.1M | 134.2M |
| Other operating expenses | — | — | — | — |
| Operating income | -49.5M | -10.8M | -16.9M | -17.5M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 4.5M | 14.9M | 5.2M | 4.9M |
| Other income expense | 1.9M | -4.0M | -4.5M | -9.9M |
| Pretax income | -52.1M | -29.7M | -26.6M | -32.4M |
| Tax provision | 961K | -564K | 751K | 1.1M |
| Net income | -53.1M | -29.1M | -27.4M | -33.4M |
| Basic EPS | -1.4 | -0.8 | -0.7 | -0.9 |
| Diluted EPS | -1.4 | -0.8 | -0.7 | -0.9 |
| Basic average shares | 39.2M | 38.7M | 38.5M | 38.0M |
| Diluted average shares | 39.2M | 38.7M | 38.5M | 38.0M |
| EBITDA | -12.6M | 13.2M | -2.7M | -4.5M |
| Net income from continuing op. | -53.1M | -29.1M | -27.4M | -33.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |